This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

Designed by European Vaccine Initiative

 

Services

TRANSVAC2 offers a wide range of services, the majority of which can be accessed free-of-charge.  These services range from shorter services lasting a few weeks, to longer services lasting several months.  All of the available services and the institutions involved are summarised below.

Vaccine R&D Pipeline

TNA 1:

Cross-platform screening

and optimisation

Antigen discovery

Formulation

Animal

studies

Process

Development

cGMP

Manufacture

Industrial

Scale-up

Pre-licensure

Clinical Trials

Licensure

Post-licensure

Clinical Trials

 
 

Platforms

TRANSVAC’s services are organised in four different platforms: Technology, Immunocorrelates and System Biology, Animal Models and Clinical Trial Support. Applicants are encouraged to follow an integrated approach by applying for complementing services. Suggestions for complementing services are shown in the overview diagram and under the individual services.

Technology

Kitchenware

 

Immunocorrelates & Systems Biology

 

Animal Models

Kitchenware

 

Clinical Trial Support